Kees L. M. C. Franken

10.4k citations

155 papers · 7.2k indexed · h-index 49

Immunology top 0.5%
Infectious Diseases top 0.2%
Epidemiology top 0.5%
Molecular Biology top 5%
Surgery top 2%

Co-authors: Tom H. M. Ottenhoff Krista E. van Meijgaarden Jan W. Drijfhout Annemieke Geluk Rienk Offringa Sjoerd H. van der Burg Cornelis J.M. Melief Susan J. F. van den Eeden
Topics: Tuberculosis Research and Epidemiology (76 papers)Mycobacterium research and diagnosis (59 papers)Immunotherapy and Immune Responses (44 papers)
Cited by: Immunology Infectious Diseases Epidemiology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Communications
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Kees L. M. C. Franken

152 papers receiving 7.1k citations

Peers

Countries citing papers authored by Kees L. M. C. Franken

Since Specialization

Citations

This map shows the geographic impact of Kees L. M. C. Franken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees L. M. C. Franken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees L. M. C. Franken more than expected).

Fields of papers citing papers by Kees L. M. C. Franken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees L. M. C. Franken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees L. M. C. Franken. The network helps show where Kees L. M. C. Franken may publish in the future.

Co-authorship network of co-authors of Kees L. M. C. Franken

This figure shows the co-authorship network connecting the top 25 collaborators of Kees L. M. C. Franken. A scholar is included among the top collaborators of Kees L. M. C. Franken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees L. M. C. Franken. Kees L. M. C. Franken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conformation of HLA-E/peptide complex guides interaction with two novel HLA-E receptors: Stabilin 1 and 2 2025 ·PLoS ONE ·(unknown),(unknown),Kees L. M. C. Franken,Tom H. M. Ottenhoff,Ruud H. Wijdeven,Simone A. Joosten	0
2	The role of IgA and IgG in Mycobacterium tuberculosis infection: a cross-sectional study in Ethiopia 2025 ·Clinical & Experimental Immunology ·(unknown),(unknown),(unknown),Yonas Abebe,Tom H. M. Ottenhoff,Kees L. M. C. Franken,Fekadu Abebe,Liya Wassie	0
3	Mtb-Specific HLA-E-Restricted T Cells Are Induced during Mtb Infection but Not after BCG Administration in Non-Human Primates and Humans 2024 ·Vaccines ·(unknown),(unknown),Iman Satti,Andrew White,Karin Dijkman,(unknown),Krista E. van Meijgaarden,Kees L. M. C. Franken,Julia L. Marshall,Tom H. M. Ottenhoff,Thomas J. Scriba,Helen McShane,Sally Sharpe,Frank A. W. Verreck,Simone A. Joosten	2
4	Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis 2024 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown),Susan J. F. van den Eeden,Krista E. van Meijgaarden,Kees L. M. C. Franken,Suzanne van Veen,Annemieke Geluk,Joke A. Bouwstra,Tom H. M. Ottenhoff	5
5	Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine 2024 ·European Journal of Pharmaceutical Sciences ·(unknown),Susan J. F. van den Eeden,Krista E. van Meijgaarden,Kees L. M. C. Franken,Suzanne van Veen,Annemieke Geluk,Joke A. Bouwstra,T.H.M. Ottenhoff	1
6	IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors 2021 ·Journal for ImmunoTherapy of Cancer ·Elham Beyranvand Nejad,(unknown),Marit J van Elsas,Jan Willem Kleinovink,Hans‐Willi Mittrücker,Kees L. M. C. Franken,Sylvia Heink,Thomas Korn,Ramon Arens,Thorbald van Hall,Sjoerd H. van der Burg	27
7	Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues 2020 ·The Journal of Immunology ·Paula Ruibal,Kees L. M. C. Franken,Krista E. van Meijgaarden,(unknown),(unknown),Mirjam H.M. Heemskerk,Tom H. M. Ottenhoff,Simone A. Joosten	25
8	Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer 2019 ·OncoImmunology ·(unknown),Marcel Camps,Jitske van den Bulk,Elena Tondini,(unknown),Dina Ruano,Kees L. M. C. Franken,George M. C. Janssen,Arnoud H. de Ru,Dmitri V. Filippov,Ramon Arens,Peter A. van Veelen,Noel F.C.C. de Miranda,Ferry Ossendorp	56
9	Humoral Responses to Rv1733c, Rv0081, Rv1735c, and Rv1737c DosR Regulon-Encoded Proteins of Mycobacterium tuberculosis in Individuals with Latent Tuberculosis Infection 2017 ·Journal of Immunology Research ·(unknown),Angela Nalwoga,Jonathan Levin,Kees L. M. C. Franken,Tom H. M. Ottenhoff,Alison M. Elliott,Stephen Cose,Irene Andia Biraro	12
10	Detection of IgG1 antibodies against Mycobacterium tuberculosis DosR and Rpf antigens in tuberculosis patients before and after chemotherapy 2015 ·Tuberculosis ·(unknown),(unknown),Kees L. M. C. Franken,(unknown),Ana Paula Ferreira,Tom H. M. Ottenhoff,Henrique Couto Teixeira	19
11	Pro- and Anti-Inflammatory Cytokines against Rv2031 Are Elevated during Latent Tuberculosis: A Study in Cohorts of Tuberculosis Patients, Household Contacts and Community Controls in an Endemic Setting 2015 ·PLoS ONE ·Mulugeta Belay,Mengistu Legesse,Adane Mihret,Yonas Bekele,Tom H. M. Ottenhoff,Kees L. M. C. Franken,Gunnar Bjune,Fekadu Abebe	35
12	CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity 2012 ·Clinical & Experimental Immunology ·(unknown),(unknown),A. A. Verrijn Stuart,Yvonne E. Fillié,Kees L. M. C. Franken,Jan W. Drijfhout,Bart O. Roep	37
13	T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy 2011 ·Clinical Cancer Research ·Esther P.M. Tjin,Debby Konijnenberg,(unknown),Henk Mallo,Jan W. Drijfhout,Kees L. M. C. Franken,Chantal M.A.M. van der Horst,Jan D. Bos,Omgo E. Nieweg,Bin B. R. Kroon,John B.A.G. Haanen,Cornelis J.M. Melief,Florry A. Vyth‐Dreese,Rosalie M. Luiten	32
14	CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity 2007 ·The Journal of Immunology ·Martijn S. Bijker,Susan J. F. van den Eeden,Kees L. M. C. Franken,Cornelis J.M. Melief,Rienk Offringa,Sjoerd H. van der Burg	218
15	Adenovirus-Specific CD4+ T Cell Clones Recognizing Endogenous Antigen Inhibit Viral Replication In Vitro through Cognate Interaction 2006 ·The Journal of Immunology ·Bianca Heemskerk,Tamara van Vreeswijk,Louise A. Veltrop‐Duits,Claudia C. Sombroek,Kees L. M. C. Franken,Renate M. Verhoosel,Pieter S. Hiemstra,Daphne van Leeuwen,Maaike E. Ressing,René E. M. Toes,Maarten J. D. van Tol,Marco W. Schilham	35
16	Human CD4⁺ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus 2006 ·European Journal of Immunology ·Louise A. Veltrop‐Duits,Bianca Heemskerk,Claudia C. Sombroek,Tamara van Vreeswijk,Sophie Gubbels,René E. M. Toes,Cornelis J.M. Melief,Kees L. M. C. Franken,Menzo Havenga,Maarten J. D. van Tol,Marco W. Schilham	36
17	Intraocular Tumor Antigen Drains Specifically to Submandibular Lymph Nodes, Resulting in an Abortive Cytotoxic T Cell Reaction 2004 ·The Journal of Immunology ·Zita F. H. M. Boonman,Geertje J. D. van Mierlo,Marieke F. Fransen,Kees L. M. C. Franken,Rienk Offringa,Cornelis J.M. Melief,Martine J. Jager,René E. M. Toes	27
18	Immunological Crossreactivity of the Mycobacterium leprae CFP‐10 with its Homologue in Mycobacterium tuberculosis 2004 ·Scandinavian Journal of Immunology ·Annemieke Geluk,Krista E. van Meijgaarden,Kees L. M. C. Franken,Brigitte Wieles,Sandra M. Arend,W. R. Faber,Bernard Naafs,T.H.M. Ottenhoff	59
19	Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model 2004 ·Vaccine ·Marij J.P. Welters,Dmitri V. Filippov,Susan J. F. van den Eeden,Kees L. M. C. Franken,Jan Nouta,A. Rob P.M. Valentijn,Gijs A. van der Marel,Herman S. Overkleeft,Grayson B. Lipford,Rienk Offringa,Cornelis J.M. Melief,Jacques H. van Boom,Sjoerd H. van der Burg,Jan W. Drijfhout	15
20	Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans 2000 ·The Journal of Immunology* ·Annemieke Geluk,Krista E. van Meijgaarden,Kees L. M. C. Franken,Jan W. Drijfhout,Sushila D’Souza,Antje Necker,Kris Huygen,Tom H. M. Ottenhoff	129

About Kees L. M. C. Franken

Kees L. M. C. Franken is a scholar working on Infectious Diseases, Immunology and Epidemiology, having authored 155 papers that have together received 7.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (76 papers), Mycobacterium research and diagnosis (59 papers) and Immunotherapy and Immune Responses (44 papers). The work is most often cited by research in Immunology (3.7k citations), Infectious Diseases (3.2k citations) and Epidemiology (3.2k citations). Kees L. M. C. Franken has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Tom H. M. Ottenhoff, Krista E. van Meijgaarden, Jan W. Drijfhout, Annemieke Geluk, Rienk Offringa, Sjoerd H. van der Burg, Cornelis J.M. Melief, Susan J. F. van den Eeden, Michèl R. Klein and May Young Lin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact